Key result
Adaptive neuro-fuzzy inference system diagnoses CAD with ~83% accuracy, outperforming logistic regression.
Why the study?
Accurate diagnosis of cardiac disease is vital, prompting the evaluation of machine learning and statistical methods for predicting coronary artery disease.
Does an adaptive neuro-fuzzy inference system (ANFIS) improve diagnostic accuracy for coronary artery disease compared to statistical methods (FDA and LR) in a cohort of 7385 subjects?
Cohort (n=7,385)
Does an adaptive neuro-fuzzy inference system (ANFIS) improve diagnostic accuracy for coronary artery disease compared to statistical methods (FDA and LR) in a cohort of 7385 subjects?
Absolute Event Rate: 83.4% vs 72.4%
An adaptive neuro-fuzzy inference system (ANFIS) provides superior diagnostic accuracy for coronary artery disease compared to traditional statistical methods like logistic regression and flexible discriminant analysis.
Background: The accurate diagnosis of cardiac disease is vital in managing patients' health. Data mining and machine learning techniques play an important role in the diagnosis of heart disease. We aimed to examine the diagnostic performances of an adaptive neuro-fuzzy inference system (ANFIS) for predicting coronary artery disease and compare this with two statistical methods: flexible discriminant analysis (FDA) and logistic regression (LR). Methods: The data of this study is the result of descriptive-analytical research from the study of Mashhad. We used ANFIS, LR, and FDA to predict coronary artery disease. A total of 7385 subjects were recruited as part of the Mashhad Stroke and Heart Atherosclerotic Disorders (MASHAD) cohort study. The data set contained demographic, serum biochemical parameters, anthropometric, and many other variables. To evaluate the ability of trained ANFIS, LR, and FDA models to diagnose coronary artery disease, we used the Hold-Out method.For analyzing data, we used SPSS v25, R 4.0.4, and MATLAB 2018 software. Results: The accuracy, sensitivity, specificity, Mean squared error (MSE) , and area under the roc curve (AUC) for ANFIS were 83.4%, 80%, 86%, 0.166 and 83.4%. The corresponding values based on the LR method were 72.4%, 74%, 70% , 0.175 and 81.5% and for the FDA method, these measurements were 77.7%, 74%, 81%, 0.223, and 77.6%, respectively. Conclusion: There was a significant difference between the accuracy of these three methods. The present findings showed that ANFIS was the most accurate method for diagnosing coronary artery disease compared with LR and FDA methods. Thus, it could be a helpful tool to aid medical decision-making for the diagnosis of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Rajabzadeh et al. (2023) conducted a cohort in Coronary artery disease (n=7,385). Adaptive neuro-fuzzy inference system (ANFIS) vs. Logistic regression (LR) and flexible discriminant analysis (FDA) was evaluated on Accuracy for diagnosing coronary artery disease. An adaptive neuro-fuzzy inference system achieved higher accuracy (83.4%) for diagnosing coronary artery disease compared to logistic regression (72.4%) and flexible discriminant analysis (77.7%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: